“Beyond PD-1/PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance” (2026) Journal of Biomolecules, Pathogenesis and Therapeutics, 2(1). Available at: https://jbptjournal.org/index.php/jbpt/article/view/33 (Accessed: 10 April 2026).